Xin Han
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 23
- Ubiquitin and proteasome pathways 16
- RNA and protein synthesis mechanisms 4
-
- Asymmetric Synthesis and Catalysis 6
- Synthesis and Catalytic Reactions 6
- Chemical Synthesis and Reactions 3
- Co-authors
- Shaomeng Wang (8 shared papers)Hai‐Bing Zhou (15 shared papers)Chune Dong (13 shared papers)Yi Sun (5 shared papers)Lijie Zhao (6 shared papers)Mi Wang (3 shared papers)Chao‐Yie Yang (3 shared papers)Weiguo Xiang (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (13 papers)RSC Advances (4 papers)European Journal of Medicinal Chemistry (2 papers)Neoplasia (2 papers)Organic & Biomolecular Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Xin Han
51 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 86
- Hematology 390
- Oncology 675
- Molecular Biology 1.7k
- Organic Chemistry 550
- Immunology 185
Countries citing papers authored by Xin Han
This map shows the geographic impact of Xin Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Han more than expected).
Fields of papers citing papers by Xin Han
This network shows the impact of papers produced by Xin Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Han. The network helps show where Xin Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 338 | |
| 2 | 2018 | 262 | |
| 3 | 2000 | 211 | |
| 4 | 2019 | 177 | |
| 5 | 2021 | 124 | |
| 6 | 2021 | 117 | |
| 7 | 2020 | 116 | |
| 8 | 2011 | 80 | |
| 9 | 2016 | 78 | |
| 10 | 2020 | 69 | |
| 11 | 2022 | 67 | |
| 12 | 2014 | 66 | |
| 13 | 2017 | 60 | |
| 14 | 2022 | 58 | |
| 15 | 2022 | 57 | |
| 16 | 2007 | 51 | |
| 17 | 2023 | 51 | |
| 18 | 2013 | 48 | |
| 19 | 2017 | 46 | |
| 20 | 2023 | 46 |
About Xin Han
Xin Han is a scholar working on Molecular Biology, Organic Chemistry, Hematology, Oncology and Developmental Neuroscience, having authored 56 papers that have together received 2.6k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (23 papers), Ubiquitin and proteasome pathways (16 papers), Peptidase Inhibition and Analysis (10 papers), Multiple Myeloma Research and Treatments (8 papers), Asymmetric Synthesis and Catalysis (6 papers), Synthesis and Catalytic Reactions (6 papers), RNA and protein synthesis mechanisms (4 papers) and Chemical Synthesis and Reactions (3 papers). The work is most often cited by research in Hematology (390 citations), Oncology (675 citations), Molecular Biology (1.7k citations), Organic Chemistry (550 citations) and Immunology (185 citations). Xin Han has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Shaomeng Wang, Hai‐Bing Zhou, Chune Dong, Yi Sun, Lijie Zhao, Mi Wang, Chao‐Yie Yang, Weiguo Xiang, Chong Qin and Donna McEachern. Their work appears in journals such as Journal of Medicinal Chemistry, RSC Advances, European Journal of Medicinal Chemistry, Neoplasia and Organic & Biomolecular Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.